Adenosine: A potential mediator of immunosuppression in multiple organ failure

Current Opinion in Pharmacology

Volumn 2, Issue 4, 2002, Pages 440-444

  Haskó, György ^a   Deitch, Edwin A ^a   Szabó, Csaba ^a   Németh, Zoltán H ^a   Vizi, E Sylvester ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA; IMMUNOLOGICAL ADJUVANT; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; CAUSE OF DEATH; CELL ACTIVATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; EXTRACELLULAR SPACE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INFECTION; INJURY; INTENSIVE CARE UNIT; MULTIPLE ORGAN FAILURE; PANCREATITIS; PRIORITY JOURNAL; SHOCK; TH2 CELL; ANIMAL; DRUG EFFECT; IMMUNOLOGY; METABOLISM; REVIEW; SECRETION; T LYMPHOCYTE;

ADENOSINE; ADJUVANTS, IMMUNOLOGIC; ANIMALS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MULTIPLE ORGAN FAILURE; T-LYMPHOCYTES;

EID: 0036667395     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4892(02)00172-8     Document Type: Review

References (47)

1. Multiple organ failure. Pathophysiology and potential future therapy
2. MOF/MODS, SIRS: An update
3. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
4. Clinical trials for severe sepsis. Past failures, and future hopes
5. Immunologic dissonance: A continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS)
6. The immunologic response to injury
7. Immune dysfunction in murine polymicrobial sepsis: Mediators, macrophages, lymphocytes and apoptosis
8. Sepsis syndromes: Understanding the role of innate and acquired immunity
9. + T lymphocytes in humans
10. The sympathetic nerve - An integrative interface between two supersystems: The brain and the immune system
11. 2-agonists prevent Th1 development by selective inhibition of interleukin 12
12. Stimulation of β-adrenoceptors inhibits endotoxin-induced IL-12 production in normal and IL-10 deficient mice
13. Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system
14. Ischemic-like condition releases norepinephrine and purines from different sources in superfused rat spleen strips
15. x7 receptors
16. Increased release of ATP from endothelial cells during acute inflammation
17. Plasma levels of high-energy compounds compared with severity of illness in critically ill patients in the intensive care unit
18. Concentration of purine compounds in the cerebrospinal fluid of infants suffering from sepsis, convulsions and hydrocephalus
19. High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock
20. 2a receptor-dependent and independent mechanisms
21. Adenosine, an endogenous anti-inflammatory agent
22. 3 adenosine receptors
23. 2B adenosine receptor expression in macrophages: A mechanism of macrophage deactivation
24. 2A receptors in human monocytic THP-1 cells
25. 2A adenosine receptors in human peripheral blood cells
26. 2B adenosine receptors in human lymphocytes: Their role in T cell activation
27. 3 adenosine receptors in Jurkat T cells
28. Adenosine receptors are expressed during differentiation of monocytes to macrophages in vitro. Implications for regulation of phagocytosis
29. + antigen expression
30. Adenosine receptor agonists differentially regulate IL-10, TNF-α and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice
31. 2 receptors on rat Kupffer cells
32. Differential regulatory effects of adenosine on cytokine release by activated human monocytes
33. 3 adenosine receptor gene in mice and its effect on stimulated inflammatory cells
34. Expression and function of adenosine receptors in human dendritic cells
35. Adenosine enhances IL-10 secretion by human monocytes
36. Regulation of thymocyte proliferation by endogenous adenosine and adenosine deaminase
37. Differential inhibition of lymphocyte function by 2-chloroadenosine
38. Purinergic modulation of T-lymphocyte activation: Differential susceptibility of distinct activation steps and correlation with intracellular 3′,5′-cyclic adenosine monophosphate accumulation
39. 2+-mediated mechanisms
40. Insights into thymic purine metabolism and adenosine deaminase deficiency revealed by transgenic mice overexpressing ecto-5′-nucleotidase (CD73)
41. Adenosine induced immunosuppression: The role of the adenosine receptor-adenylate cyclase interaction in the alteration of T-lymphocyte surface phenotype and immunoregulatory function
42. Cytokine patterns at the site of mycobacterial infection
43. Receptors for purines and pyrimidines
44. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors
45. Molecular approach to adenosine receptors: Receptor-mediated mechanisms of tissue protection
46. Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction
47. Neutrophil-epithelial crosstalk at the intestinal lumenal surface mediated by reciprocal secretion of adenosine and IL-6